Barros Sónia, Roseira Joana, Caldeira Paulo, Vaz Ana Margarida, Guerreiro Horácio, Codon Oscar
Gastroenterology Department, Algarve University Medical Center, Faro, Portugal.
Radiation Oncology Department, Algarve Radio-Oncology Clinic, Faro, Portugal.
GE Port J Gastroenterol. 2020 Dec 9;28(6):416-419. doi: 10.1159/000511647. eCollection 2021 Nov-Dec.
Prostate cancer is the second most frequent cancer in men worldwide. Dose escalation is currently the standard of care for the treatment of prostate cancer with radiation therapy. However, the rectum tends to be the dose-limiting structure when treating prostate cancer, given its proximity. The injection of biodegradable spacers between the prostate and the rectum may optimize radiotherapy treatment delivery for patients with localized disease. Nevertheless, although the overall complication rate of spacers is marginal, the benefits of spacer technologies need to be evaluated against the complication risks such as rectum perforation/necrosis. We report a case of a 59-year-old man with a diagnosis of prostate adenocarcinoma for whom hormonal treatment followed by intensity modulated radiation therapy (IMRT) was proposed. A biodegradable and expandable balloon (BioProtect®) was injected into the perirectal space without detectable immediate complications. One month later, the patient presented with a 3-day persistent rectal bleeding. The investigation confirmed a rectal perforation by the balloon spacer system.
前列腺癌是全球男性中第二常见的癌症。剂量递增目前是前列腺癌放射治疗的标准治疗方法。然而,由于直肠位置靠近,在治疗前列腺癌时它往往是剂量限制结构。在前列腺和直肠之间注射可生物降解的间隔物可能会优化局部疾病患者的放射治疗。尽管如此,虽然间隔物的总体并发症发生率很低,但间隔物技术的益处需要与直肠穿孔/坏死等并发症风险进行评估。我们报告了一例59岁诊断为前列腺腺癌的男性病例,该患者接受了激素治疗,随后建议进行调强放射治疗(IMRT)。一个可生物降解且可扩张的球囊(BioProtect®)被注入直肠周围间隙,未发现即刻并发症。一个月后,患者出现持续3天的直肠出血。检查证实是球囊间隔系统导致了直肠穿孔。